Bolt Biotherapeutics 宣布收购 Prana Therapies 并同步完成 1.2 亿美元私募配售,以推进 PRA-216 在多类高价值炎症适应症中的开发

美股速递
Oct 23

Bolt Biotherapeutics 宣布收购 Prana Therapies,并同步完成 1.2 亿美元私募配售,旨在推动 PRA-216 在多个高价值炎症适应症中的进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10